In vitro and in vivo investigations manifested that ARID1A inhibited cell survival, proliferation, and tumor growth, functioning as a gatekeeper for cell proliferation and a caretaker of genome stability in SCLC cells. Here, ARID1A is linked to small cell lung carcinoma.